1010. Deputy Gary Gannon asked the Minister for Health if his attention has been drawn to the fact that an application for Xonvea was rejected for inclusion on the drugs payment scheme by the HSE on the advice of the National Centre for Pharmacoeconomics, NCPE, which determined that the medicine is not good value for money and that comes at a higher cost than other ways to manage this condition (details supplied); and the other ways of managing hyperemesis gravidarum that were assessed by the HSE and NCPE. [12153/21]

Summary

1010. Deputy Gary Gannon asked the Minister for Health if his attention has been drawn to the fact that an application for Xonvea was rejected for inclusion on the drugs payment scheme by the HSE on the advice of the National Centre for Pharmacoeconomics, NCPE, which determined that the medicine is not good value for money and that comes at a higher cost than other ways to manage this condition (details supplied); and the other ways of managing hyperemesis gravidarum that were assessed by the HSE and NCPE. [12153/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Prescriptions Charges

  xml · EN · 3 March 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.